August 29th 2025
The FDA approved Monjuvi with Revlimid and Rituxan for follicular lymphoma, the same combination that brought survivor Troy Anderson a lasting response.
August 29th 2025
August 28th 2025
August 28th 2025
August 27th 2025
July 13th 2025
July 6th 2025
July 5th 2025
July 3rd 2025